RSS FeedArchive
March 2021 October 2020 May 2020 October 2019 July 2019 May 2019 February 2019 October 2018 July 2018 March 2018 January 2018 November 2017 March 2017 October 2016 June 2016 May 2016 January 2016 December 2015 October 2015 July 2015 June 2015 May 2015 April 2015 December 2014 October 2014 September 2014 August 2014 July 2014 June 2014 April 2014 February 2014 December 2013 September 2013 July 2013 June 2013 April 2013 March 2013 February 2013 January 2013 December 2012 November 2012 October 2012 July 2012 May 2012
Subjects
3D cell culture (1)Contagion CDC (1)DNA sequencing (1)Epigenetic Inheritance (1)biotech peregrine pharma Eureka pharma MHCI/peptide complex bavituximab (1)cancer (1)drug development (1)epidemics (1)epigenetics (2)film review (1)irrproducible results (1)vaccine technology (1)wolves dogs evolution (1)
Results for 2012-11
A wealth of new epigenetic drugs
November 27, 2012
While there are only four FDA-approved drugs that target the epigenome, there are a large number in various stages of development, as explained by Dr. Peter Ordentlich at the Third World Epigenetics Summit held in Boston in July, 2012. Ordentlich, who is VP of Transl...
A lethal epigenetic cocktail
November 26, 2012
There are two deeply disturbing properties of epigenetic inheritance that have been receiving much attention of late. The first is the ability of certain classes of chemicals to cause epigenetic changes that can be transmitted transgenerationally. The seco...
Teutonic Technology Transcends Trends
November 2, 2012
Germany’s commitment to advanced technology is legendary, going back to the industrial revolution in the 19th century. As competition with China and other Asian countries has grown in recent decades, the German response has been to develop...